S. Ruan

J. Humm, S. Larson, C. Hudis, 2019, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

PET-based compartmental modeling of 124I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer

J. Humm, S. Larson, D. Scheinberg, 2015, European Journal of Nuclear Medicine and Molecular Imaging.

Pharmacokinetics, Biodistribution, and Radiation Dosimetry for 89Zr-Trastuzumab in Patients with Esophagogastric Cancer

S. Larson, Jason S. Lewis, Y. Janjigian, 2018, The Journal of Nuclear Medicine.

Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor mo

C Clifton Ling, Pat Zanzonico, Andrei Pugachev, 2005, International journal of radiation oncology, biology, physics.

Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody

J. Humm, S. Larson, D. Scheinberg, 2011, Physics in medicine and biology.

First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake

Danny F. Martinez, S. Larson, M. Morris, 2016, The Journal of Nuclear Medicine.

Glycosyltransferase Levels Determine Ganglioside Patterns Melanoma and Neuroblastoma Cells : Relative Glycosylation Pathways in the Biosynthesis of Gangliosides in Updated Version

K. Lloyd, S. Ruan, 2006 .

Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer

Jason S. Lewis, J. Carrasquillo, W. Weber, 2019, Clinical Cancer Research.

First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer

Gary A Ulaner, Pat B Zanzonico, D. Lake, 2017, The Journal of Nuclear Medicine.

Optimizing the sequence of combination therapy with radiolabeled antibodies and fractionated external beam.

J. Humm, S. Larson, A. Jungbluth, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A stereotactic method for the three-dimensional registration of multi-modality biologic images in animals: NMR, PET, histology, and autoradiography.

Y Chen, C C Ling, K Zakian, 2003, Medical physics.

Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial.

J. Humm, S. Larson, M. Gönen, 2007, The Lancet. Oncology.

First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting

Michael Gordon, Jedd D. Wolchok, Anna M. Wu, 2019, The Journal of Nuclear Medicine.

Analysis of melanoma cells stably transfected with beta 1,4GalNAc transferase (GM2/GD2 synthase) cDNA: relative glycosyltransferase levels play a dominant role in determining ganglioside expression.

K. Furukawa, K. Lloyd, S. Ruan, 1995, Archives of biochemistry and biophysics.

Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade Glioma

C. Brennan, C. Rudin, F. Chen, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

PET imaging of (86)Y-labeled anti-Lewis Y monoclonal antibodies in a nude mouse model: comparison between (86)Y and (111)In radiolabels.

J. Humm, S. Larson, M. Brechbiel, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Changes in FDG Tumor Uptake during and after Fractionated Radiation Therapy in a Rodent Tumor Xenograft.

C. Ling, Y. Erdi, J. Humm, 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors.

S. Larson, P. Zanzonico, R. Finn, 2002, Nuclear medicine and biology.

Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning

John Humm, Pat Zanzonico, Ronald Finn, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

Iodination of annexin V for imaging apoptosis.

C. Ling, J. Humm, R. Finn, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

PET Imaging of 86Y-Labeled Anti-Lewis Y Monoclonal Antibodies in a Nude Mouse Model: Comparison Between 86Y and 111In Radiolabels

J. Humm, S. Larson, M. Brechbiel, 2001 .

Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)

S. Larson, L. Schwartz, G. Abou-Alfa, 2017, Cancer Chemotherapy and Pharmacology.